This implies that in breast cancer cells, enhancing the expression of hsa-miR-214-3p improves the activity and proportion of immune cells through the regulation of B7H3, thus obstructing the immune escape of breast cancer cells. The gene discussed is CD276; the disease is breast carcinoma.